[go: up one dir, main page]

WO1991014003A2 - Characterization and analysis of polymorphic vntr loci - Google Patents

Characterization and analysis of polymorphic vntr loci Download PDF

Info

Publication number
WO1991014003A2
WO1991014003A2 PCT/US1991/001628 US9101628W WO9114003A2 WO 1991014003 A2 WO1991014003 A2 WO 1991014003A2 US 9101628 W US9101628 W US 9101628W WO 9114003 A2 WO9114003 A2 WO 9114003A2
Authority
WO
WIPO (PCT)
Prior art keywords
vntr
locus
amplification
primers
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1991/001628
Other languages
French (fr)
Other versions
WO1991014003A3 (en
Inventor
Glenn T. Horn
Brenda L. Richards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IG Laboratories Inc
Original Assignee
IG Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Laboratories Inc filed Critical IG Laboratories Inc
Publication of WO1991014003A2 publication Critical patent/WO1991014003A2/en
Publication of WO1991014003A3 publication Critical patent/WO1991014003A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • VNTR variable number of tandem repeats
  • VNTR polymorphisms are currently analyzed as restriction fragment length polymorphisms (RFLPs) via Southern blot transfer and hybridization to radioactive probes.
  • Southern transfer is used to detect many kinds of polymorphisms , it requires large amounts of sample DNA that is able to be digested by restrict ⁇ ion enzymes, and can take up to a week to complete.
  • a VNTR segment designated pYNZ32 human gene mapping (HGM) locus D4S125) was isolated as part of a family of cosmid clones hybridizing to a synthetic oligonucleotide probe from the zeta globin repeat sequence. Nakamura t a1. , Science 2 jj : 1616- 1622 (1987).
  • the pYNZ32 probe was reported to reveal a six-allele VNTR identified by several enzymes, including Taql and Pstl. Nakamura Y. et al. , Nucl_. Acids Res . 16(9):4186 (1988). It was described as having a heterozygosity of 58% with Taql in 94 unrelated Caucasians and was later closely linked to the locus responsible for Huntington's disease, located on the short arm of chromosome 4. Nakamura Y. et al. , Science 235:1616-1622 (1987); and MacDonald, M.E. et al. , J. Clin. Invest. 84:1013-1016 (1989). As such, the pYNZ32 probe has been used in restriction fragment length polymorphism (RFLP) analysis as a linkage marker for Huntington's disease.
  • RFLP restriction fragment length polymorphism
  • the present invention is a method for determining polymorphisms which occur in VNTR loci, such as the YNZ32 and YNZ22 locus. Primers for YNZ32 are described. According to the method, sequences flanking a VNTR locus of interest are determined and used to construct amplification primers which can direct amplification across the VNTR locus. The primers are extended using polymerase chain reaction (PCR) to produce amplification products which can be directly analyzed. Variations in the length of the amplified products are then used to identify sequence polymorphisms. Sequence variations which do not affect the size of the amplification products can be further analyzed by digesting the amplification products with various restriction enzymes to generate restriction fragments . The invention can be used in genetic linkage studies, paternity testing, forensic identification or as a diagnostic for polymorphisms.
  • PCR polymerase chain reaction
  • Figure 1 shows a restriction map of the pYNZ32 insert. Restriction sites are indicated as R, Rsal; P, Pstl; T, Taql; H, Hindlll; B, Bgll; M, Mspl. The hatched portion indicates the repeat region. The double-thick lines represent the areas from which the sequence data in Figure 2 was taken. Arrows beneath the map show approximate positions for the amplifi ⁇ cation primers.
  • Figure 2 shows the partial nucleotide sequence of plasmid pYNZ32.
  • Figure 3 shows sequence diversity within the repeated region of pYNZ32 which is shown in Figure 2.
  • Figure 4A shows the results of agarose gel electrophoresis of PCR products amplified from total genomic DNA.
  • Lanes 1-3 amplification of DNA from a father (showing allelic products designated A and F) , a child (products F and G) , and a mother (C and G) ;
  • lanes 4,5,7,8 amplification of DNA from 4 unrelated indi ⁇ viduals giving amplified products B and E, A and E, D and I, and D and G, respectively;
  • lane 6 Rsal DNA marker fragments from bacteriophage ⁇ . Sizes in bp are indicated to the right.
  • Figure 4B shows a Southern blot analysis of Taql digested DNA of some of the same samples amplified above, and hybridized with probe pYNZ32. Overloading of the first two lanes has slightly reduced the apparent size of the bands. The exposure of these lanes has been reduced photographically. Sizes in Kbp are shown on the right.
  • Figure 4C is a schematic showing the relative positions of the YNZ32 amplified products versus the ⁇ DNA/Rsal marker fragments.
  • the largest marker frag ⁇ ment represents a doublet of 2196 and 2183 bp , and the smallest fragment shown is 1436 bp .
  • Figure 5 shows Mspl restriction maps for twelve YNZ32 amplified allele products.
  • the products are designated A to I (largest to smallest), and some products of the same size are shown which differ in their Mspl digestion pattern.
  • the alleles are aligned at the conserved Mspl site, the second site in most of the alleles (except for I which has only one Mspl site) .
  • a star indicates the presence of the unique Bgll site.
  • This invention pertains to methods for amplifying polymorphic VNTR loci and to methods for determining polymorphisms which occur at the VNTR locus.
  • PCR poly erase chain reaction
  • nucleotide sequences flanking a VNTR locus of interest are first determined, From that information, two oligonucleotide primers are designed to direct amplification across the VNTR region.
  • One oligonucleotide primer comprises a nucleotide sequence which hybridizes to the region flanking one end of the VNTR sequence.
  • the second primer comprises a nucleotide sequence which hybridizes to the region of flanking the other end of the VNTR sequence. Hybridization of the primers to other portions of the VNTR can be prevented by restricting the primers to those nucleotides which are unique to the flanking sequences and avoiding segments of DNA which are partially homologous to the repeat unit.
  • the primers are then subjected to conditions sufficient to direct amplification across the VNTR locus. This can be accomplished using PCR techniques described by Mullis, K.B. et al. , U.S. Patent No. 4,683,195 and Mullis, K.B. , U.S. Patent No. 4,683,202. The teachings of these patents are incorporated by reference herein.
  • the resulting amplification products can then be analyzed for size variations using gel electrophoresis techniques. Variations observed in the length of the fragments are indicative of sequence polymorphisms . Sequence polymorphisms which do not affect the length of the PCR product can be determined by digesting them with various restriction enzymes to produce fragments from which a restriction map can be determined. The lengths of the fragments are indicative of sequence polymorphisms .
  • the methods of this invention provide rapid analysis of polymorphisms at VNTR loci using small amounts of sample DNA. Such analysis of these regions is extremely useful in genetic linkage studies, paternity testing and forensic identification.
  • One advantage is that cumbersome RFLP-based assays are not needed.
  • the present invention is based on the characteri ⁇ zation of the highly polymorphic VNTR locus pYNZ32, which had been previously isolated. Nakamura, Y. et *___• - Science 235:1616-1622 (1987). For the first time, a restriction map for this locus has been determined, as well as the nucleotide sequence of a substantial portion of this locus.
  • oligonucleotides derived from this sequence can be synthesized. Such synthetic oligonucleotides are useful as primers for amplification techniques and can be used to direct amplification across the VNTR region. DNA sequencing in the areas within and flanking the repeated segment allowed for the design of specific amplification primers.
  • the repeated region of pYNZ32 consists of an imperfectly duplicated 27 base pair motif, 16 bases of which are more highly conserved. Allelic products from PCR amplification were resolved into nine different size classes ranging from approxi ⁇ mately 1400 to 2200 base pairs. Additional poly- morphism was revealed when the amplified products were analyzed by restriction enzyme digestion.
  • the cloned insert in probe pYNZ32 was mapped for various restriction sites (Figure 1) .
  • the distance between the two Taql sites suggests they are responsible for the known Taql RFLP (2.3-2.8 Kbp) for YNZ32 on human genomic DNA Southern blots. Nakamura Y. et al. , Science 235:1616-1622 (1987).
  • the Pstl site is most likely involved with the Pstl polymorphism, with the other site lying further to the right of the segment contained within the cloned fragment.
  • Mspl RFLP range of 1.2-1.8 Kbp for YNZ32 on genomic DNA Southern blots (Nakamura Y. e t a ⁇ . , Nucl ⁇ _Acijis_Res ⁇ 16:4186 (1988))
  • four fragments in the 400-700 bp range were observed, consistent with the map of the cloned probe ( Figure 1) .
  • the sequences flanking the repeat region were also characterized. The information was used to construct primers for amplification of the repeat region.
  • Primer GH301 and GH290 were used to amplify the YNZ32 locus from human genomic DNA samples using polymerase chain reaction techniques.
  • the amplifica ⁇ tion products ranged in size from approximately 1400 to 2200 base pairs.
  • These products were grouped into 9 size classes designated A to I in order of decreasing size (amplification from the pYNZ32 clone yielded a "D" allele) , according to their positions relative to the fragments in Rsal digested lambda DNA ( Figures 4A and 4C) .
  • Each size class encompasses a narrow range of amplified allelic products differing slightly in length.
  • allelic size classes indicate that additional polymorphism might be elucidated by restriction enzyme mapping.
  • Several amplified products were therefore isolated, reamplified, and analyzed by digestion with Mspl or Bgll . Twelve of these products having different digestion patterns were also mapped with Mspl ( Figure 5). Most of the products have three Mspl sites; the maps in Figure 5 are lined up at the second Mspl site, which is conserved in all but one of the alleles.
  • Allelic products Al and Fl are missing the first Mspl site, while products Bl, Cl and Gl are missing the third Mspl site.
  • the II allele has only one internal Mspl site.
  • the sequence of the repeated region of pYNZ32 shows several interesting features.
  • the 27 bp repeated motif is neither conserved nor exactly tandemly ar- ranged, in contrast with other VNTR loci. This sug ⁇ gests that YNZ32 may have once been a perfect tandem repeat which has since diverged. This sequence diver ⁇ gence of the repeat may prevent changes in size seen in some other VNTR loci. Jeffreys, A.J. et al. , Nature H2:278-281 (1988). We were unable to detect major similarities between this sequence and the pYNZ22 repeat (Wolff, R.K. et a1.
  • a search of sequences listed in GenBank revealed the greatest similarity to a polypyrimidine repeat isolated from the mouse genome. Deugau, K.V. et 1. , Anal ⁇ _Biochem ⁇ 129:88-97 (1983) .
  • Amplification of the YNZ32 locus by PCR is a rapid alternative to analysis by other assays. Both the amplif cation and agarose gel analysis of YNZ32 can be performed within four hours.
  • the direct visualization of PCR products on ethidium bromide-stained agarose gels allows the allelic products to be better resolved than the bands seen on Southern blots. Amplified products are also amenable to restriction enzyme analysis, which reveals additional polymorphism.
  • the YNZ32 locus contains poly ⁇ morphic restriction sites.
  • This additional poly ⁇ morphism can be used to discriminate alleles of similar size, thereby increasing the diagnostic utility of this locus.
  • the Bl and B2 alleles ( Figure 5) give the same size PCR products, but when digested with Mspl, release distinctive fragments of 775 or 605 bp , respectively. Similar discrimination between certain alleles can also be achieved using the single Bgll site, which is present only in some chromosomes.
  • the clone pYNZ32 was obtained from Y. Nakamura and is also available from the ATCC (#57548). It has a total insert size of 4.1 Kbp.
  • High molecular weight genomic DNA used for amplification was prepared by standard methods (Maniatis T. et al. , "Molecular Cloning - A Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1982). Oligonucleotide primers were synthesized on an Applied Biosystems 380B Synthesizer. Agarose gels were made from SEAKEM GTG agarose (American Bioanalytical) and were run in IX TBE buffer with 0.1 ⁇ g/ml ethidium bromide at 10 volts per cm.
  • the pYNZ32 clone was mapped with several re ⁇ striction enzymes. The positions of Mspl sites were more accurately determined by partial Mspl digestion of
  • DNA fragments flanking and within the repeated region of pYNZ32 were subcloned and sequenced ( Figure 2).
  • the first segment shown here runs from the left Taql site until about 130 base pairs into the repeat. Also shown are the locations of the Mspl and Pstl restriction sites used in RFLP analysis. The arrow indicates the location and direction of the GH301 oligonucleotide primer used in PCR amplification. The repeated region begins just after the Pstl site, and the more highly conserved core segment (Figure 3) is underlined.
  • the second segment shows the final 130 base pairs of the repeat, the location and orientation of the GH290 primer, and the sequence flanking the repeated region. Additional sequence was determined between these segments and is include in Figure 3, but could not be accurately placed due to the repetitive nature of this region.
  • PCR amplification reactions were performed using AmpliTaq DNA polymerase and a DNA Thermal Cycler (Perkin Elmer) .
  • One ⁇ g of human genomic DNA was amplified for 28 cycles of 10 seconds at 94°C, 10 seconds at 55 ⁇ C, and 30 seconds at 74 ⁇ C, with a final soak for 10 minutes at 74°C.
  • the reaction buffer used was described previously (Saiki, R.K. et al.. , ⁇ £i. nc:e 129:487-491 (1988)), with the exception that KC1 was not included, and the concentration of MgCl- was reduced to about 1.2mM.
  • the amplification should be optimized empirically.
  • the yield of PCR product was also reduced when amplification primers were used at less than I ⁇ H .
  • PCR products were analyzed on 1% agarose gels.
  • a Rsal digest of bacteriophage ⁇ DNA was used as markers for the amplified alleles since it has several fragments in the appropriate size range.
  • Amplified allelic products are designated A to I (largest to smallest) by their positions relative to these size markers ( Figure 4C) . Those products within a single size class but having internal variation are distinguished by numbers (e.g. , product Bl vs. B2) . Further analysis of the amplified DNA was performed by electroeluting the DNA from a gel slice (Maniatis, T. et al.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention pertains to characterization of the YNZ32 VNTR locus and to methods for detecting polymorphisms at a highly polymorphic VNTR locus. Polymorphisms are detected by VNTR locus amplification and enzymatic digestion of the amplification products. Variations observed in restriction maps of the fragments are then used to assess the polymorphisms. Primers for VNTR amplification of the YNZ32 locus are described.

Description

CHARACTERIZATIO _AND_ANALYSIS_OF POLYMORPHIC VNTR LOCI
β_!:-_-S£-^£_iS-_£-[_-_._l__._-tSX__._l£-_£_ϊ
The human genome is interspersed with segments of directly repeated DNA. Some of these loci vary in the number of tandem repeats and have been designated variable number of tandem repeats (VNTR). Nakamura Y. __.__ al. , Science 2__.5, : 1616-1622 (1987). These repeated regions can be retrieved from human cosmid libraries by screening with oligonucleotides from known VNTRs, then further localizing the repeat on a smaller fragment. Nakamura, Y. et al, Iϊ i.d. Many of the probes for VNTR loci reveal more than two alleles; their extensive polymorphism makes them useful in genetic mapping, clinical linkage analysis, and DNA fingerprinting.
However, few of these loci have been characterized in detail .
VNTR polymorphisms are currently analyzed as restriction fragment length polymorphisms (RFLPs) via Southern blot transfer and hybridization to radioactive probes. Although Southern transfer is used to detect many kinds of polymorphisms , it requires large amounts of sample DNA that is able to be digested by restrict¬ ion enzymes, and can take up to a week to complete. A VNTR segment designated pYNZ32 (human gene mapping (HGM) locus D4S125) was isolated as part of a family of cosmid clones hybridizing to a synthetic oligonucleotide probe from the zeta globin repeat sequence. Nakamura t a1. , Science 2 jj : 1616- 1622 (1987). The pYNZ32 probe was reported to reveal a six-allele VNTR identified by several enzymes, including Taql and Pstl. Nakamura Y. et al. , Nucl_. Acids Res . 16(9):4186 (1988). It was described as having a heterozygosity of 58% with Taql in 94 unrelated Caucasians and was later closely linked to the locus responsible for Huntington's disease, located on the short arm of chromosome 4. Nakamura Y. et al. , Science 235:1616-1622 (1987); and MacDonald, M.E. et al. , J. Clin. Invest. 84:1013-1016 (1989). As such, the pYNZ32 probe has been used in restriction fragment length polymorphism (RFLP) analysis as a linkage marker for Huntington's disease.
It would be desirable to provide an efficient method for determining polymorphisms at a VNTR locus which can be used as a diagnostic.
Summary of the Invention
The present invention is a method for determining polymorphisms which occur in VNTR loci, such as the YNZ32 and YNZ22 locus. Primers for YNZ32 are described. According to the method, sequences flanking a VNTR locus of interest are determined and used to construct amplification primers which can direct amplification across the VNTR locus. The primers are extended using polymerase chain reaction (PCR) to produce amplification products which can be directly analyzed. Variations in the length of the amplified products are then used to identify sequence polymorphisms. Sequence variations which do not affect the size of the amplification products can be further analyzed by digesting the amplification products with various restriction enzymes to generate restriction fragments . The invention can be used in genetic linkage studies, paternity testing, forensic identification or as a diagnostic for polymorphisms.
Bri.e _De £r^£tj.on_of_the_Drawl.ng Figure 1 shows a restriction map of the pYNZ32 insert. Restriction sites are indicated as R, Rsal; P, Pstl; T, Taql; H, Hindlll; B, Bgll; M, Mspl. The hatched portion indicates the repeat region. The double-thick lines represent the areas from which the sequence data in Figure 2 was taken. Arrows beneath the map show approximate positions for the amplifi¬ cation primers.
Figure 2 shows the partial nucleotide sequence of plasmid pYNZ32. Figure 3 shows sequence diversity within the repeated region of pYNZ32 which is shown in Figure 2.
Figure 4A shows the results of agarose gel electrophoresis of PCR products amplified from total genomic DNA. Lanes 1-3: amplification of DNA from a father (showing allelic products designated A and F) , a child (products F and G) , and a mother (C and G) ; lanes 4,5,7,8: amplification of DNA from 4 unrelated indi¬ viduals giving amplified products B and E, A and E, D and I, and D and G, respectively; lane 6: Rsal DNA marker fragments from bacteriophage λ. Sizes in bp are indicated to the right.
Figure 4B shows a Southern blot analysis of Taql digested DNA of some of the same samples amplified above, and hybridized with probe pYNZ32. Overloading of the first two lanes has slightly reduced the apparent size of the bands. The exposure of these lanes has been reduced photographically. Sizes in Kbp are shown on the right.
Figure 4C is a schematic showing the relative positions of the YNZ32 amplified products versus the λDNA/Rsal marker fragments. The largest marker frag¬ ment represents a doublet of 2196 and 2183 bp , and the smallest fragment shown is 1436 bp .
Figure 5 shows Mspl restriction maps for twelve YNZ32 amplified allele products. The products are designated A to I (largest to smallest), and some products of the same size are shown which differ in their Mspl digestion pattern. The alleles are aligned at the conserved Mspl site, the second site in most of the alleles (except for I which has only one Mspl site) . A star indicates the presence of the unique Bgll site.
5-_._Ξi_:ii£-_:_2_L__£__.AE_ϊi££_£.f_£^
This invention pertains to methods for amplifying polymorphic VNTR loci and to methods for determining polymorphisms which occur at the VNTR locus. By poly erase chain reaction (PCR) techniques, a segment of the VNTR locus can be amplified and its amplifi¬ cation products analyzed. As a result of this method, it is possible to identify sequence polymorphisms by determining size variations in the PCR products.
According to the method, nucleotide sequences flanking a VNTR locus of interest are first determined, From that information, two oligonucleotide primers are designed to direct amplification across the VNTR region. One oligonucleotide primer comprises a nucleotide sequence which hybridizes to the region flanking one end of the VNTR sequence. The second primer comprises a nucleotide sequence which hybridizes to the region of flanking the other end of the VNTR sequence. Hybridization of the primers to other portions of the VNTR can be prevented by restricting the primers to those nucleotides which are unique to the flanking sequences and avoiding segments of DNA which are partially homologous to the repeat unit. The primers are then subjected to conditions sufficient to direct amplification across the VNTR locus. This can be accomplished using PCR techniques described by Mullis, K.B. et al. , U.S. Patent No. 4,683,195 and Mullis, K.B. , U.S. Patent No. 4,683,202. The teachings of these patents are incorporated by reference herein. The resulting amplification products can then be analyzed for size variations using gel electrophoresis techniques. Variations observed in the length of the fragments are indicative of sequence polymorphisms . Sequence polymorphisms which do not affect the length of the PCR product can be determined by digesting them with various restriction enzymes to produce fragments from which a restriction map can be determined. The lengths of the fragments are indicative of sequence polymorphisms .
The methods of this invention provide rapid analysis of polymorphisms at VNTR loci using small amounts of sample DNA. Such analysis of these regions is extremely useful in genetic linkage studies, paternity testing and forensic identification. One advantage is that cumbersome RFLP-based assays are not needed. The present invention is based on the characteri¬ zation of the highly polymorphic VNTR locus pYNZ32, which had been previously isolated. Nakamura, Y. et *__• - Science 235:1616-1622 (1987). For the first time, a restriction map for this locus has been determined, as well as the nucleotide sequence of a substantial portion of this locus. Based on this information, oligonucleotides derived from this sequence can be synthesized. Such synthetic oligonucleotides are useful as primers for amplification techniques and can be used to direct amplification across the VNTR region. DNA sequencing in the areas within and flanking the repeated segment allowed for the design of specific amplification primers. The repeated region of pYNZ32 consists of an imperfectly duplicated 27 base pair motif, 16 bases of which are more highly conserved. Allelic products from PCR amplification were resolved into nine different size classes ranging from approxi¬ mately 1400 to 2200 base pairs. Additional poly- morphism was revealed when the amplified products were analyzed by restriction enzyme digestion. Both the overall size variation as well as the internal sequence polymorphism were used to determine a heterozygosity value of 86% for YNZ32 in 50 unrelated individuals. The rapid analysis and improved resolution of amplified alleles on agarose gels, and the internal variability within YNZ32, increase its diagnostic utility as a VNTR and as a linkage marker for the nearby Huntington's disease gene . _ ^-£ -£ Σ_LSS__:_L £_£____?:ll£-_ ϊ_Z3^_L£cu
The cloned insert in probe pYNZ32 was mapped for various restriction sites (Figure 1) . The distance between the two Taql sites suggests they are responsible for the known Taql RFLP (2.3-2.8 Kbp) for YNZ32 on human genomic DNA Southern blots. Nakamura Y. et al. , Science 235:1616-1622 (1987). Similarly, the Pstl site is most likely involved with the Pstl polymorphism, with the other site lying further to the right of the segment contained within the cloned fragment. In contrast to a previously published Mspl RFLP range of 1.2-1.8 Kbp for YNZ32 on genomic DNA Southern blots (Nakamura Y. e t a^. , Nucl^_Acijis_Res^ 16:4186 (1988)), four fragments in the 400-700 bp range were observed, consistent with the map of the cloned probe (Figure 1) .
Sequencing of Mspl fragments within the clone revealed the tandemly repeated segment, which is approximately 1700 base pairs long and totally con- tained within the cloned insert (Figure 1) . The DNA sequences near the termini of the repeated region are shown in Figure 2, and additional sequencing was performed on internal fragments (Figure 3). This region shows strong purine/pyrimidine asymmetry, and predominantly consists of tetranucleotides CCTT and CATT. Consideration of the arrangement of these tetranucleotides suggests a 27 bp repeated motif (Figure 3), 16 bp of which are more highly conserved. However, no part of this region shows the exact tan- de ly repeated segments seen in other VNTR loci.
Jeffreys, A.J. et a1. , Nature ^12:278-281 (1988); and Wolff, R.K. et al. , Genomics 3:347-351 (1988). Amplification and Analysis
The sequences flanking the repeat region (Figure 2) were also characterized. The information was used to construct primers for amplification of the repeat region. Primer GH301 and GH290 were used to amplify the YNZ32 locus from human genomic DNA samples using polymerase chain reaction techniques. The amplifica¬ tion products ranged in size from approximately 1400 to 2200 base pairs. These products were grouped into 9 size classes designated A to I in order of decreasing size (amplification from the pYNZ32 clone yielded a "D" allele) , according to their positions relative to the fragments in Rsal digested lambda DNA (Figures 4A and 4C) . Each size class encompasses a narrow range of amplified allelic products differing slightly in length. Sizes of the PCR products from specific samples correlate with the results seen in Southern blot analysis (Figure 4B) , thus validating the use of PCR for detecting polymorphisms at the YNZ32 locus . The Mendelian inheritance of the amplified alleles is also verified in Figure 4B .
The minor variations seen within these allelic size classes indicate that additional polymorphism might be elucidated by restriction enzyme mapping. Several amplified products were therefore isolated, reamplified, and analyzed by digestion with Mspl or Bgll . Twelve of these products having different digestion patterns were also mapped with Mspl (Figure 5). Most of the products have three Mspl sites; the maps in Figure 5 are lined up at the second Mspl site, which is conserved in all but one of the alleles. Allelic products Al and Fl are missing the first Mspl site, while products Bl, Cl and Gl are missing the third Mspl site. The II allele has only one internal Mspl site. The unique Bgll site shown on the map in Figure 1 is present in only some alleles. Finally, the Mspl fragments show length variations even within an allelic size class. For example, the right-hand fragment produced by Mspl digestion is 555 bp in product Dl but only 500 bp in D2 (Figure 5).
The frequencies of alleles A to I in 50 unrelated individuals were determined (Table 1) . The largest allele (A) and the two smallest alleles (H and I) were each present in only one of these 100 chromosomes. Almost 80% of the products were found to be in the intermediate classes of D, E and F. The distribution of alleles among these individuals was consistent with Hardy-Weinberg equilibrium, and no evidence for null alleles was observed. YNZ32 was found to have a heterozygosity value of 86% for these 100 chromosomes.
TABLE 1
Frequencies of YNZ32 Allelic Products in 50 Unrelated Individuals
Allelic Approximate Frequency
Products __L____.£_i.__.]__.___ ll
A 2200 1
B 1975 7
C 1910 6
D 1850 46
E 1810 19
F 1710 14
G 1650 5
H 1560 1
I 1415 1
Analysis of the pYNZ32 (D4S125) locus has allowed this VNTR repeat to be further characterized and its analysis converted to a rapid PCR-based format. As a result, the extent of its polymerization in amplified allele products can be more thoroughly investigated.
The sequence of the repeated region of pYNZ32 shows several interesting features. The 27 bp repeated motif is neither conserved nor exactly tandemly ar- ranged, in contrast with other VNTR loci. This sug¬ gests that YNZ32 may have once been a perfect tandem repeat which has since diverged. This sequence diver¬ gence of the repeat may prevent changes in size seen in some other VNTR loci. Jeffreys, A.J. et al. , Nature H2:278-281 (1988). We were unable to detect major similarities between this sequence and the pYNZ22 repeat (Wolff, R.K. et a1. , Genomics 2:347-351 (1988)) or the zeta-globin oligonucleotide with which both of these probes were selected. Nakamura Y. e_t a1.. , i£i£S££ 2.25:1616-1622 (1987). A search of sequences listed in GenBank revealed the greatest similarity to a polypyrimidine repeat isolated from the mouse genome. Deugau, K.V. et 1. , Anal^_Biochem^ 129:88-97 (1983) .
Amplification of the YNZ32 locus by PCR is a rapid alternative to analysis by other assays. Both the amplif cation and agarose gel analysis of YNZ32 can be performed within four hours. The direct visualization of PCR products on ethidium bromide-stained agarose gels allows the allelic products to be better resolved than the bands seen on Southern blots. Amplified products are also amenable to restriction enzyme analysis, which reveals additional polymorphism.
In addition to the overall variation in length of the repeated region, the YNZ32 locus contains poly¬ morphic restriction sites. This additional poly¬ morphism can be used to discriminate alleles of similar size, thereby increasing the diagnostic utility of this locus. For example, the Bl and B2 alleles (Figure 5) give the same size PCR products, but when digested with Mspl, release distinctive fragments of 775 or 605 bp , respectively. Similar discrimination between certain alleles can also be achieved using the single Bgll site, which is present only in some chromosomes.
The ability to rapidly amplify and analyze this highly polymorphic locus should help support both clinical and research studies. The extensive hetero- zygosity of YNZ32 alleles is often critical in discriminating chromosomes in the large pedigrees used in linkage analysis of Huntington's disease. MacDonald, M.E. et al. , J _Clin._Inve£t^ 84:1013-1016 (1989) . This polymorphism may also be of use in more general 'DNA fingerprinting' studies. Finally, the divergent nature of the repeated sequence at this locus may assist in understanding the creation, evolution, and stability of VNTR segments. Jarman, A. P. and R.A. Wells, Trends_in_Genet_. 5:367-371 (1989).
The invention will be further illustrated by the following exemplification, which is not intended to be limiting in any way.
E EMPLIFICATION
Materials^ and Methods
The clone pYNZ32 was obtained from Y. Nakamura and is also available from the ATCC (#57548). It has a total insert size of 4.1 Kbp. High molecular weight genomic DNA used for amplification was prepared by standard methods (Maniatis T. et al. , "Molecular Cloning - A Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1982). Oligonucleotide primers were synthesized on an Applied Biosystems 380B Synthesizer. Agarose gels were made from SEAKEM GTG agarose (American Bioanalytical) and were run in IX TBE buffer with 0.1 μg/ml ethidium bromide at 10 volts per cm.
££_L2___52-_:____. 3-_: S£__.2i_-
The pYNZ32 clone was mapped with several re¬ striction enzymes. The positions of Mspl sites were more accurately determined by partial Mspl digestion of
32 the clone after labeling at one end with a - P-dATP. Smith, H.O. and M.L. Bernstiel, Nucl^_Aci.ds_Re ^ 2: 2387 (1976). Mspl fragments of pYNZ32 were subcloned into Ml3mpl8 and sequenced using standard dideoxy methods. Sambrook, J. jit a 1. , "Molecular Cloning - A Laboratory Manual", Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1989). Figure 3 shows the sequence diversity within the repeated region of pYNZ32. The upper line shows the sequence of the proposed 27 base pair repeated motif, with the more conserved 16 base pair region underlined. Below it are segments from the pYNZ32 sequence, aligned to show similarities with the repeated core. The exact positions of some of the aligned segments within pYNZ32 are not known, but are generally listed from left to right relative to Figure 1. A dash indicates identity with the core, and spaces have been inserted for two segments to improve the alignment. An asterisk indi¬ cates that this segment is immediately followed by another segment similar to the motif. Figure 2 shows the results of sequencing the areas flanking the repeated region. PCR primers GH290 and GH301 were designed from these regions and have the following nucleotide sequences:
GH290 : 5 ' -GTCAGCACCTCAGACCAGAG-3 ' GH301: 5 ' -CTGTGGGACCTCGGCTAAGC-3 '
DNA fragments flanking and within the repeated region of pYNZ32 (Figure 1) were subcloned and sequenced (Figure 2). The first segment shown here runs from the left Taql site until about 130 base pairs into the repeat. Also shown are the locations of the Mspl and Pstl restriction sites used in RFLP analysis. The arrow indicates the location and direction of the GH301 oligonucleotide primer used in PCR amplification. The repeated region begins just after the Pstl site, and the more highly conserved core segment (Figure 3) is underlined. The second segment shows the final 130 base pairs of the repeat, the location and orientation of the GH290 primer, and the sequence flanking the repeated region. Additional sequence was determined between these segments and is include in Figure 3, but could not be accurately placed due to the repetitive nature of this region.
_^5EH_fi£≤-__._ B_≤S_____^Ξ_-Ll∑__..---£
PCR amplification reactions were performed using AmpliTaq DNA polymerase and a DNA Thermal Cycler (Perkin Elmer) . One μg of human genomic DNA was amplified for 28 cycles of 10 seconds at 94°C, 10 seconds at 55βC, and 30 seconds at 74βC, with a final soak for 10 minutes at 74°C. The reaction buffer used was described previously (Saiki, R.K. et al.. , ∑£i. nc:e 129:487-491 (1988)), with the exception that KC1 was not included, and the concentration of MgCl- was reduced to about 1.2mM. The amplification should be optimized empirically. The yield of PCR product was also reduced when amplification primers were used at less than IμH .
PCR products were analyzed on 1% agarose gels. A Rsal digest of bacteriophage λ DNA was used as markers for the amplified alleles since it has several fragments in the appropriate size range. Amplified allelic products are designated A to I (largest to smallest) by their positions relative to these size markers (Figure 4C) . Those products within a single size class but having internal variation are distinguished by numbers (e.g. , product Bl vs. B2) . Further analysis of the amplified DNA was performed by electroeluting the DNA from a gel slice (Maniatis, T. et al. , "Molecular Cloning - A Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1982)), concentrating a DNA on the Centricon-30 microconcentrator (Amicon) , and reamplifying individual products and analyzing their Mspl and Bgll digestion patterns on 2% and 1% agarose gels, respectively. In addition, 12 individually amplified products were also mapped (Figure 5) using Mspl partial digestion. Smith, H.O. and M.L. Bernstiel, Nuc 1^_AcIds_Res^ 2: 2387 (1976).
Five DNA samples that were amplified by PCR were also analyzed as Taql digests on a Southern blot. Maniatis, T. e t al . , "Molecular Cloning - A Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1982). The blot (Figure 4B) was hybridized with the 2900 bp Pstl-Rsal fragment of pYNZ32 shown on the map of Figure 1.
Figure imgf000017_0001
Those skilled in the art will recognize or be able to ascertain, using no more than routine experimen¬ tation, many equivalents to the specific embodiments of the invention described herein. These and all other equivalents are intended to be encompassed by the following claims.

Claims

1. A method of detecting polymorphisms at a poly¬ morphic variable number of tandem repeats (VNTR) locus, comprising the steps of: a) providing two oligonucleotide primers which specifically direct amplification across the
VNTR locus, wherein one of the primers comprises a nucleotide sequence which hybri¬ dizes to the region flanking one end of the VNTR sequence and the other of the primers comprises a nucleotide sequence which hybri¬ dizes to the region flanking the other end of the VNTR sequence; b) contacting the two primers with genomic DNA thought to contain the VNTR of interest, under conditions sufficient to direct ampli¬ fication across the VNTR locus and produce amplification products thereof; and c) determining size variations in the amplification products, wherein the variations are indicative of sequence poly¬ morphisms.
2. The method of Claim 1, wherein the amplification is performed by polymerase chain reaction.
3. The method of Claim 2, wherein the VNTR locus is YNZ32 and the oligonucleotide primers have nucleotide sequences shown in Figure 2 or portion thereof, for directing amplification across the YNZ32 locus.
4. The method of Claim 3, the oligonucleotide primers have the sequences 5 ' -GTCAGCACCTCAGACCAGAG-3 ' and 5 ' -CTGTGGGACCTCGGCTAAGC-3 ' .
5. The method of Claim 1, further comprising the step of: d) digesting the amplification products with restriction enzymes to produce DNA fragments having lengths which correspond to sequence polymorphisms .
6. A method of amplifying a polymorphic VNTR locus, comprising the steps of: a) providing two oligonucleotide primers which specifically direct amplification across the VNTR locus, wherein one of the primers comprises a nucleotide sequence which hybri¬ dizes to the region flanking one end of the VNTR sequence and the other of the primers comprises a nucleotide sequence which hybri¬ dizes to the region flanking the other end of the VNTR sequenced; and b) hybridizing the primers to genomic DNA thought to contain the VNTR of interest, under conditions sufficient to direct ampli¬ fication across the VNTR locus and produce amplification products thereof.
7. The method of Claim 6, wherein the amplification is performed by polymerase chain reaction.
8. The method of Claim 7, wherein the VNTR locus is YNZ32 and the oligonucleotide primers have nucleotide sequences shown in Figure 2 or portion thereof, for directing amplification across the YNZ32 locus.
9. The method of Claim 8, the oligonucleotide primers have the sequences 5 ' -GTCAGCACCTCAGACCAGAG-3 ' and
5' -CTGTGGGACCTCGGCTAAGC-3' .
10. An oligonucleotide primer having the nucleotide sequences shown in Figure 2 or portion thereof, for directing amplification across the YNZ32 locus .
11. The primer of Claim 10, having the sequences 5' -GTCAGCACCTCAGACCAGAG-3' or
5' -CTGTGGGACCTCGGCTAAGC-3' .
PCT/US1991/001628 1990-03-09 1991-03-11 Characterization and analysis of polymorphic vntr loci Ceased WO1991014003A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49128690A 1990-03-09 1990-03-09
US491,286 1990-03-09

Publications (2)

Publication Number Publication Date
WO1991014003A2 true WO1991014003A2 (en) 1991-09-19
WO1991014003A3 WO1991014003A3 (en) 1991-10-31

Family

ID=23951561

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/001628 Ceased WO1991014003A2 (en) 1990-03-09 1991-03-11 Characterization and analysis of polymorphic vntr loci

Country Status (1)

Country Link
WO (1) WO1991014003A2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534858A1 (en) * 1991-09-24 1993-03-31 Keygene N.V. Selective restriction fragment amplification : a general method for DNA fingerprinting
WO1993011264A1 (en) * 1991-12-04 1993-06-10 E.I. Du Pont De Nemours And Company Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
US6808633B1 (en) 1999-06-23 2004-10-26 Hitachi, Ltd. Centrifugal separator and sample preparation device using the separator
US7026115B1 (en) 1991-09-24 2006-04-11 Keygene N.V. Selective restriction fragment amplification: fingerprinting
US7329490B2 (en) 2003-09-15 2008-02-12 Bristol-Myers Squibb Company Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
EP2080766A1 (en) 2001-06-06 2009-07-22 Bristol-Myers Squibb Company B7-related nucleic acids and polypeptides useful for immunomodulation
US7935488B2 (en) 1991-09-24 2011-05-03 Keygene N.V. Selective restriction fragment amplification: fingerprinting
WO2012104851A1 (en) 2011-01-31 2012-08-09 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
US8455190B2 (en) 2007-08-01 2013-06-04 Dana-Farber Cancer Institute, Inc. Enrichment of a target sequence
US9133490B2 (en) 2012-05-16 2015-09-15 Transgenomic, Inc. Step-up method for COLD-PCR enrichment
US9957556B2 (en) 2010-03-08 2018-05-01 Dana-Farber Cancer Institute, Inc. Full COLD-PCR enrichment with reference blocking sequence
US10913977B2 (en) 2013-07-24 2021-02-09 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable enrichment of minor DNA alleles by limiting denaturation time in PCR or simply enable enrichment of minor DNA alleles by limiting the denaturation time in PCR
US11130992B2 (en) 2011-03-31 2021-09-28 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable multiplex COLD-PCR
US11174511B2 (en) 2017-07-24 2021-11-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
US11371090B2 (en) 2016-12-12 2022-06-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929070T2 (en) * 1988-02-18 2000-05-25 The University Of Utah, Salt Lake City USE OF DNA SAMPLES WITH VARIABLE NUMBER OF TANDEM REPETITIVE SITES FOR GENETIC IDENTIFICATION
GB2228086A (en) * 1988-11-25 1990-08-15 Ici Plc Characterisation of genomic DNA

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026115B1 (en) 1991-09-24 2006-04-11 Keygene N.V. Selective restriction fragment amplification: fingerprinting
WO1993006239A1 (en) * 1991-09-24 1993-04-01 Keygene N.V. Selective restriction fragment amplification: a general method for dna fingerprinting
EP0534858A1 (en) * 1991-09-24 1993-03-31 Keygene N.V. Selective restriction fragment amplification : a general method for DNA fingerprinting
US7572583B2 (en) 1991-09-24 2009-08-11 Keygene N.V. Selective restriction fragment amplification: fingerprinting
US7935488B2 (en) 1991-09-24 2011-05-03 Keygene N.V. Selective restriction fragment amplification: fingerprinting
EP0969102A3 (en) * 1991-09-24 2000-02-23 Keygene N.V. Primers, kits and sets of restriction fragments used in selective restriction fragment amplification
US6045994A (en) * 1991-09-24 2000-04-04 Keygene N.V. Selective restriction fragment amplification: fingerprinting
US5753467A (en) * 1991-12-04 1998-05-19 E. I. Du Pont De Nemours And Company Method for the identification of microorganisms by the utilization of directed and arbitrary DNA amplification
WO1993011264A1 (en) * 1991-12-04 1993-06-10 E.I. Du Pont De Nemours And Company Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification
US6387626B1 (en) 1997-06-06 2002-05-14 Orchid Biosciences, Inc. Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces
US6136962A (en) * 1997-06-06 2000-10-24 Orchid Biosciences, Inc. Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
US6808633B1 (en) 1999-06-23 2004-10-26 Hitachi, Ltd. Centrifugal separator and sample preparation device using the separator
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
EP2080766A1 (en) 2001-06-06 2009-07-22 Bristol-Myers Squibb Company B7-related nucleic acids and polypeptides useful for immunomodulation
US7329490B2 (en) 2003-09-15 2008-02-12 Bristol-Myers Squibb Company Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
US8455190B2 (en) 2007-08-01 2013-06-04 Dana-Farber Cancer Institute, Inc. Enrichment of a target sequence
US9957556B2 (en) 2010-03-08 2018-05-01 Dana-Farber Cancer Institute, Inc. Full COLD-PCR enrichment with reference blocking sequence
US11174510B2 (en) 2010-03-08 2021-11-16 Dana-Farber Cancer Institute, Inc. Full COLD-PCR enrichment with reference blocking sequence
WO2012104851A1 (en) 2011-01-31 2012-08-09 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
US11130992B2 (en) 2011-03-31 2021-09-28 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable multiplex COLD-PCR
US9133490B2 (en) 2012-05-16 2015-09-15 Transgenomic, Inc. Step-up method for COLD-PCR enrichment
US10913977B2 (en) 2013-07-24 2021-02-09 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable enrichment of minor DNA alleles by limiting denaturation time in PCR or simply enable enrichment of minor DNA alleles by limiting the denaturation time in PCR
US11371090B2 (en) 2016-12-12 2022-06-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection
US11174511B2 (en) 2017-07-24 2021-11-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture

Also Published As

Publication number Publication date
WO1991014003A3 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
EP0414469B1 (en) Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
Gibbs et al. Detection of single DNA base differences by competitive oligonucleotide priming
US7563581B2 (en) Methods for detecting and localizing DNA mutations by extension of differentially fragmented DNA
US6110709A (en) Cleaved amplified modified polymorphic sequence detection methods
JP3816109B2 (en) Artificial mismatch hybridization
EP0663923B1 (en) Three highly informative microsatellite repeat polymorphic dna markers
US4946773A (en) Detection of base pair mismatches using RNAase A
WO1991014003A2 (en) Characterization and analysis of polymorphic vntr loci
HK1008053B (en) Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
Nickerson et al. Identification of clusters of biallelic polymorphic sequence-tagged sites (pSTSs) that generate highly informative and automatable markers for genetic linkage mapping
WO1995015400A1 (en) Genotyping by simultaneous analysis of multiple microsatellite loci
EP0812211A1 (en) Cleaved amplified rflp detection methods
US6051379A (en) Cancer susceptibility mutations of BRCA2
WO2000047766A1 (en) Method for detecting variant nucleotides using arms multiplex amplification
JPH06504443A (en) DNA sequence related to isolated fragile X syndrome
Wong et al. Detection of mitochondrial DNA mutations using temporal temperature gradient gel electrophoresis
WO2005093101A1 (en) Nucleic acid sequencing
US6232065B1 (en) Analysis of gene family expression
US5773649A (en) DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
JP2001520052A (en) A method for determining coat color genotype in pigs
Richards et al. Characterization and rapid analysis of the highly polymorphic VNTR locus D4S125 (YNZ32), closely linked to the Huntington disease gene
Witowski et al. Microarray-based detection of select cardiovascular disease markers
Lemieux Plant genotyping based on analysis of single nucleotide polymorphisms using microarrays.
KR100635926B1 (en) Polynucleotides, Primers, and Methods for Salmon Genotyping and Family Line Identification Using Mitochondrial DNA COI-ND3-ND4L Region Monobasic Polymorphism
US20040197775A1 (en) Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.22/91,UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

NENP Non-entry into the national phase

Ref country code: CA